Ascentage Pharma (Suzhou) Co., Ltd.
Records under this name other than the patents Ascentage Pharma (Suzhou) Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 40 patents it holds.
Showing 1 to 2 of 2 · Back to Ascentage Pharma (Suzhou) Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,498,928 | Macrocyclic Spiroethers as MCL-1 Inhibitors Held by another company In force · High confidence | In force | High confidence | |
| US 9,783,539 | Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors Lapsed on the fee record Ended Oct 10, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 10, 2021 | USPTO record |